JAMA has issued its first-ever Expression of Concern over a 2007 study of hip protectors in the elderly that came under scrutiny from Federal regulators.
As the Boston Globe was first to report yesterday, the journal’s editor and executive deputy editor wrote in a notice published online: Continue reading JAMA’s first-ever Expression of Concern appears for hip protector study
Renewable and Sustainable Energy Reviews has retracted a 2008 paper by a group from the United States and Botswana, citing plagiarism and unauthorized use of data.
The article, “Solar chimney power generation project—The case for Botswana,” discussed a project by the Botswanan military to develop a power plant based on the chimney design. The paper is no longer available online, but we found this Wikipedia entry that mentions it: Continue reading Solar energy paper retracted for text, data misuse
A group of researchers from Austria, Canada, Germany, and the U.S. have retracted a 2008 paper in the Journal of Immunology after being unable to verify the contents of some key figures.
Here’s the notice: Continue reading Immunology paper retracted because “documents were not archived with due diligence”
Why just have three peer-reviewed publications when you can reuse figures to publish a fourth?
That’s the sort of thinking that got one research group slapped with a retraction of their 2009 study, “Carbon Nanotubes Are Able To Penetrate Plant Seed Coat and Dramatically Affect Seed Germination and Plant Growth.”
The journal ACS Nano, published by the American Chemical Society, issued the retraction on Aug. 20: Continue reading Reused figures lead to two chemistry retractions, one correction
A group of researchers from Texas and Zimbabwe has lost a paper after they tried publishing it twice — first in the European Journal of Clinical Pharmacology, and then in the International Journal of Clinical Pharmacy.
Here’s the notice: Continue reading Study linking antidepressants to diabetes retracted when authors publish it twice
The journal Group Dynamics: Theory, Research, and Practice is retracting a 2003 paper by psychologist Lawrence Sanna, who appears to have been fabricating his data. Sanna’s work, Retraction Watch readers may recall, came under the scrutiny of Uri Simonsohn, who also investigated Dirk Smeesters’ research.
Here’s the notice, which offers an impressive amount of back story as these things go: Continue reading “Invalid data” prompt retraction of another paper from psychologist Sanna
Less than 24 hours after the publication of a study showing no link between XMRV, aka xenotropic murine leukemia-related virus, and chronic fatigue syndrome (CFS), the authors of a a study claiming a link between the virus and prostate cancer have has been retractedit. The move comes along with the publication of a new study showing that no such link exists.
Here’s the notice, from PLoS Pathogens: Continue reading Another XMRV shoe drops: PLoS Pathogens study linking prostate cancer to virus retracted
The authors of a paper suggesting that cassava, a starchy vegetable that’s a major food source in much of the developing world, could one day be turned into a food staple “capable of supplying inexpensive, plant-based proteins for food, feed and industrial applications” have retracted it, following an institutional investigation that failed to find critical supporting data.
Here’s the notice for the PLoS ONE study, “Transgenic Biofortification of the Starchy Staple Cassava (Manihot esculenta) Generates a Novel Sink for Protein:” Continue reading PLoS ONE GMO cassava paper retracted after data “could not be found”
Well, it only took 17 years.
As two retraction notices in the September 15 issue of the Journal of Immunology note:
On October 19, 1995, the Office of Research Integrity at the National Institutes of Health found that Weishu Y. Weiser, Ph.D., formerly of the Harvard Medical School at Brigham and Women’s Hospital, committed scientific misconduct by falsifying data in biomedical research supported by two Public Health Service grants. As a result, she agreed to submit a letter to The Journal of Immunology to retract this article. The offices of The Journal of Immunology have no record of receiving such a letter and hence the article is now being retracted.
The retractions, for “Recombinant Migration Inhibitory Factor Induces Nitric Oxide Synthase in Murine Macrophages” and “Human Recombinant Migration Inhibitory Factor Activates Human Macrophages to Kill Leishmania donovani,” both say the same thing.
“Recombinant Migration Inhibitory Factor Induces Nitric Oxide Synthase in Murine Macrophages” has been cited 66 times, according to Thomson Scientific’s Web of Knowledge — 40 of those times since the ORI’s report was released. The numbers for the Leishmania paper are almost identical: Continue reading ORI findings lead to two retractions — nearly 17 years later
We have four more retractions by Dipak Das, the disgraced UConn researcher found by the university to have committed 145 counts of misconduct. All appear in the Journal of Molecular and Cellular Cardiology (we left the journal off when we initially posted, as commenters noted):
“Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling,” cited 28 times, according to Thomson Scientific’s Web of Knowledge:
Continue reading Retraction count for Dipak Das rises to 17